Anna Grisi Promoted within PediaMed Pharmaceuticals; Grisi Named Brand Manager.

FLORENCE, Ky. -- PediaMed - The Pediatrics Company (TM), a company specializing in the health and wellbeing of children, today announced the promotion of Anna Grisi to Brand Manager for AccuHist(R) and Viravan(R) allergy, cough and cold medications.

With her notable pharmaceutical marketing experience, Grisi quickly became an asset as Assistant Brand Manager at PediaMed. In her new position as Brand Manager, Grisi's primary role will include working with the team responsible for analysis, planning, development and implementation of marketing strategy.

"Anna joined PediaMed with an extensive background in healthcare and marketing and has proved skillful and resourceful in marketing strategy," said Cameron Durrant, MD, MBA, President of PediaMed. "This opportunity places her in a position of greater leadership, and we look forward to her continued growth."

Prior to joining PediaMed, Grisi worked in marketing at Duramed Pharmaceuticals/Barr Laboratories, a pharmaceutical company engaged in the development, manufacture and marketing of generic and proprietary prescription pharmaceuticals. She filled several different positions during her time with Barr, including Associate Product Manager, where she facilitated the launch of Cenestin(R) in 1999, Marketing Associate and most recently Manager of Label and Development and Control.

Grisi holds an undergraduate degree in economics from the University of Cincinnati.

About PediaMed - The Pediatrics Company(TM)

PediaMed - The Pediatrics Company(TM), is a privately held, specialty pharmaceutical company focused on providing safe and effective medicine to pediatric patients, parents and the healthcare professionals that serve them. Key operations were first established in Q1 2001. PediaMed has established a highly productive and competent 90-person sales and marketing team and achieved profitability. Net sales tripled from 2002 to 2003.

PediaMed today focuses on providing Kidpliant(TM) prescription medicines in the field of allergy/cough/cold and in promoting Tazorac(R) acne cream and gel to pediatricians through a recently established co-marketing arrangement with Allergan. In keeping with the mission, PediaMed is identifying underserved pediatric market opportunities in the areas of respiratory/allergy, anti-infectives, gastroenterology, dermatology and central nervous system (CNS). The company is in the process of acquiring new products/opportunities to leverage its core sales and marketing competency focused in the highly underserved and rapidly growing pediatric market. The company is also building its own development pipeline.

With recent changes in the regulatory landscape regarding pediatric pharmaceuticals, the company believes that the opportunities are many and growing, and it is well positioned to take full advantage of these opportunities with pediatrics now established as the fastest growing prescription segment.

PediaMed is a member of the Union Springs, L.L.C. portfolio of companies, which includes Xanodyne Pharmaceuticals. For more information, visit the PediaMed Web site at www.pediamedpharma.com.